Clinical Trial Update: Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury [Phase 1]

View source ↗

Summary

Phase 1 imaging trial evaluating PET tracers [18F]PI-2620 and [18F]Florbetaben in military service members with blast-related mild traumatic brain injury was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• 18F-Florbetaben
• [18F]PI-2620 (PI-2620)

Snippet

Sponsor: Life Molecular Imaging SA | Conditions: Mild Traumatic Brain Injury | Phase 1 | Status: TERMINATED